Patients with high levels of lncRNA PVT1 have a significantly lower overall survival rate than those with low levels, and lncRNA PVT1 may represent a new biomarker and possible therapeutic target for patients with lung cancer [21]. This evidence concerns the gene PVT1 and lung cancer.